NeuroStar® Advanced Therapy Enhanced With Wi-Fi Capabilities

07 April 2023 | Friday | News

Fifth FDA clearance in less than two years offers greater connectivity and flexibility to improve the patient and provider experience

Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced improved internet connectivity capabilities, particularly for NeuroStar providers with restricted networks.

“By integrating Wi-Fi capability into the NeuroStar system, providers now have greater flexibility in where they place their NeuroStar system and have access to more connectivity options for TrakStar,” stated Cory Anderson, SVP of R&D and Clinical. “This latest advancement demonstrates our continued commitment to invest in technology that streamlines practice operation and allows improved access to TrakStar insights.”

NeuroStar providers using the 3.7 platform now have improved internet connectivity, granting access to all the features and benefits previously exclusive to TrakStar cloud customers while maintaining HIPAA compliance and patient security. This feature also allows data collection from additional practices, enhancing the ability to gather insights from a broader cross-section of practices.

“The new Wi-Fi feature of the NeuroStar system is exciting to have,” said Dr. Kenneth Pages, TMS of South Tampa. “It allows my practice to concentrate solely on delivering the best possible patient care while simplifying day-to-day operations.”

Neuronetics recently unveiled the first of multiple software releases for the TrakStar® Patient Data Management System this year, alongside a new educational campaign, “Get There FASTER with TrakStar,” aimed at NeuroStar providers.

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close